Neurologic Imaging

What Is the Best Initial Imaging for Suspected CNS Demyelination in an Adult?

·
What Is the Best Initial Imaging for Suspected CNS Demyelination in an Adult?

A 34-year-old woman presents to the clinic with three weeks of progressive tingling in her hands and a new sense of imbalance when walking. On examination, she has mild ataxia and brisk reflexes in her lower extremities. You suspect a central nervous system (CNS) demyelinating process like multiple sclerosis (MS). The immediate clinical question is which imaging study to order first to confirm the diagnosis and assess disease activity. This is a critical decision point, as the right initial study can accelerate diagnosis and treatment, while the wrong one can lead to delays and unnecessary radiation exposure. According to the American College of Radiology (ACR) Appropriateness Criteria, for an adult with acute or subacute sensorimotor or brainstem symptoms where demyelinating disease is suspected, MRI cervical and thoracic spine without and with IV contrast is rated Usually Appropriate.

Who Fits This Clinical Scenario?

This imaging workflow is designed for a specific patient presentation: an adult experiencing new neurologic symptoms that have developed over days to weeks (acute or subacute) and point toward a lesion in the central nervous system.

Inclusion criteria for this pathway include:

  • Patient: Adult.
  • Onset: Acute or subacute (not chronic and stable, and not hyperacute like a stroke).
  • Symptoms: Sensory changes (numbness, tingling, paresthesias), motor deficits (weakness, spasticity), or brainstem signs (diplopia, vertigo, dysarthria, ataxia).
  • Suspicion: The clinical picture suggests a demyelinating disease (e.g., MS, NMOSD) as a primary diagnostic consideration.

It is crucial to distinguish this scenario from similar presentations that require different imaging strategies. This guidance does not apply if:

  • Symptoms are clearly localized below a spinal cord level: If the patient has a distinct sensory level on their trunk with accompanying weakness and bowel/bladder dysfunction, the primary suspicion shifts to transverse myelitis. While related, this has its own specific ACR variant.
  • The patient has a known diagnosis of demyelinating disease: Imaging for a patient with established MS who is either stable (surveillance) or has new deficits (relapse assessment) follows different protocols.
  • Weakness is symmetric and progressive without clear CNS signs: If symptoms are predominantly motor, symmetric, and ascending without a sensory level, a peripheral nervous system demyelinating disease (e.g., Guillain-Barré syndrome) is more likely, prompting a different workup.

What Diagnoses Are You Working Up in This Scenario?

When ordering initial imaging for suspected CNS demyelination, you are evaluating a differential diagnosis that includes several important inflammatory and non-inflammatory conditions. The goal of imaging is to identify characteristic lesions that can confirm one diagnosis while helping to exclude others.

The most common and classic consideration is Multiple Sclerosis (MS). MS is an autoimmune disease characterized by inflammatory demyelinating plaques disseminated in time and space throughout the CNS. The typical patient is a young adult, and symptoms often correspond to plaques in the periventricular white matter, corpus callosum, brainstem, cerebellum, or spinal cord. Imaging seeks to find evidence of these plaques.

A key mimic and critical alternative diagnosis is Neuromyelitis Optica Spectrum Disorder (NMOSD). Previously considered a variant of MS, NMOSD is a distinct antibody-mediated disease (targeting aquaporin-4) that often causes more severe attacks. It classically presents with optic neuritis or longitudinally extensive transverse myelitis (LETM), where a spinal cord lesion spans three or more vertebral segments. Differentiating it from MS is vital, as some MS therapies can worsen NMOSD.

Another important consideration is Myelin Oligodendrocyte Glycoprotein (MOG) Antibody Disease (MOGAD). Like NMOSD, this is an antibody-mediated condition that can mimic MS but has a different pathophysiology and treatment approach. It can also present with optic neuritis or transverse myelitis, and imaging features can sometimes overlap with both MS and NMOSD.

Less common but consequential possibilities include infectious or parainfectious myelitis (e.g., from viruses like VZV or HSV), systemic autoimmune diseases with CNS involvement (e.g., lupus, sarcoidosis), and, rarely, vascular causes like a spinal cord infarct, though the latter typically has a more hyperacute onset.

Why Is MRI of the Spine Without and With IV Contrast the Recommended Study?

For an initial workup of suspected CNS demyelination with sensorimotor or brainstem symptoms, the ACR designates both MRI cervical and thoracic spine without and with IV contrast and MRI head without and with IV contrast as Usually Appropriate. The choice to begin with the spine, or to order both studies concurrently, often depends on the localization of the patient’s symptoms. This article focuses on the rationale for the spinal imaging component.

Superior Sensitivity for Demyelinating Plaques Magnetic Resonance Imaging (MRI) is the gold standard because of its exceptional soft-tissue contrast, which allows direct visualization of demyelinating plaques in the spinal cord and brain. T2-weighted and STIR (Short Tau Inversion Recovery) sequences are highly sensitive for detecting these lesions, which appear as high-signal-intensity foci. The cervical and thoracic regions of the spinal cord are common sites for MS plaques.

The Critical Role of Intravenous Contrast Ordering the study “without and with IV contrast” is essential.

  • Without Contrast: Pre-contrast T1 and T2/STIR sequences identify the overall burden of disease, showing both old and new lesions.
  • With Contrast: Post-contrast T1-weighted sequences with fat suppression highlight areas of active inflammation where the blood-brain barrier has broken down. These “enhancing” lesions indicate that a plaque is new or active, which is a cornerstone of the McDonald criteria for diagnosing MS (fulfilling “dissemination in time”).

Why Alternative Studies Are Rated Lower

  • CT of the Spine: All forms of Computed Tomography (CT) are rated Usually not appropriate. CT lacks the soft-tissue resolution to visualize demyelinating plaques and exposes the patient to significant ionizing radiation (adult RRL=☢☢☢☢ 10-30 mSv) without providing diagnostic value for this specific question.
  • MRI of the Lumbar Spine: An MRI lumbar spine without and with IV contrast is rated only May be appropriate. The spinal cord proper typically terminates at the L1-L2 vertebral level. While lesions can occur in the conus medullaris, they are far less common than in the cervical and thoracic cord. Ordering only a lumbar spine MRI would miss the vast majority of spinal MS plaques.

In clinical practice, if brainstem symptoms (e.g., diplopia, ataxia) are prominent, ordering both the brain and spine MRI simultaneously is a common and effective strategy to assess for dissemination in space at a single time point.

Once you’ve decided on MRI of the spine, our protocol guide covers the fundamental techniques and reading principles for the non-contrast sequences: MRI Cervical Spine Without Contrast. For this specific scenario, remember to explicitly order the study with and without IV contrast to evaluate for active inflammation.

What’s Next After MRI? Downstream Workflow

The results of the initial MRI will guide your next steps, creating a branching decision tree for patient management.

If the Study is Positive for Demyelination: If the MRI reveals lesions characteristic of a demyelinating disease (e.g., short-segment, ovoid, peripherally located plaques in the spinal cord), the immediate next step is a consultation with a neurologist. The downstream workup will likely include:

  1. Brain MRI (if not already done): To look for characteristic periventricular, juxtacortical, or infratentorial lesions to satisfy diagnostic criteria for dissemination in space.
  2. Lumbar Puncture: To test cerebrospinal fluid (CSF) for oligoclonal bands and an elevated IgG index, which are supportive of an MS diagnosis.
  3. Serologic Testing: Blood tests for AQP4-IgG and MOG-IgG antibodies are crucial to rule out NMOSD and MOGAD, respectively, as their presence would fundamentally change the diagnosis and treatment plan.

If the Study is Negative: A negative cervical and thoracic spine MRI in a patient with high clinical suspicion does not rule out a demyelinating disease. The next logical step is to image the brain. As noted, MRI head without and with IV contrast is also rated Usually Appropriate for this scenario. Some patients may have disease confined to the brain initially. If both brain and spine MRIs are negative, the focus should shift to re-evaluating the differential diagnosis, considering peripheral nerve disorders, metabolic causes, or functional neurologic disorders.

If the Study is Indeterminate: Sometimes, imaging may show a single, non-specific T2 hyperintense lesion. This finding is inconclusive. In this case, a neurology consult is still warranted. The neurologist may recommend proceeding with a brain MRI and lumbar puncture or adopting a “watch and wait” approach with follow-up imaging to see if new lesions develop, which would demonstrate dissemination in time.

Pitfalls to Avoid (and When to Get Help)

Navigating the initial workup for suspected demyelination requires careful attention to detail to avoid common errors that can delay diagnosis.

  • Pitfall 1: Ordering CT instead of MRI. This is the most common and consequential error. CT cannot visualize demyelinating plaques and delivers unnecessary radiation. For this indication, MRI is always the correct first-line modality.
  • Pitfall 2: Forgetting to order IV contrast. An MRI without contrast can show the overall lesion burden but cannot determine which lesions are active. This information is critical for diagnosis and for deciding on the urgency of treatment.
  • Pitfall 3: Ordering MRI of the wrong spinal segment. Focusing only on the lumbar spine based on leg symptoms will miss the majority of spinal cord plaques, which occur more cranially. The order should specify the cervical and thoracic spine.
  • Pitfall 4: Misinterpreting non-specific findings. Not every white matter spot on an MRI is a demyelinating plaque. Age-related white matter changes, migraine-associated spots, and post-ischemic changes can be mimics.

If the clinical picture is complex, the imaging is equivocal, or the patient’s condition is rapidly deteriorating, an urgent consultation with a neurologist is the most appropriate next step.

Related ACR Topics and Tools

For a comprehensive understanding of imaging in demyelinating diseases and access to related decision-support tools, the following resources are available:

Frequently Asked Questions

Why is both a brain and spine MRI often necessary for suspected MS?

The diagnostic criteria for Multiple Sclerosis (the McDonald criteria) require evidence of demyelinating lesions ‘disseminated in space’ and ‘disseminated in time.’ Obtaining both brain and spine MRIs at the initial presentation helps establish dissemination in space by showing lesions in at least two distinct CNS locations (e.g., periventricular in the brain and in the cervical spinal cord). Finding both enhancing (active) and non-enhancing (chronic) lesions on the same scan can help establish dissemination in time.

If my patient only has sensory symptoms in their legs, should I order a lumbar spine MRI?

No, for an initial workup of suspected central demyelination, the cervical and thoracic spine MRI is the correct first study. The sensory pathways for the legs travel through the entire spinal cord. MS plaques are most common in the cervical and thoracic regions. The spinal cord itself ends around L1-L2, so a lumbar MRI primarily images the cauda equina (peripheral nerves) and would miss the vast majority of relevant CNS lesions.

Is an MRI without contrast acceptable if the patient has a gadolinium allergy or severe renal impairment?

An MRI without contrast is rated as ‘May be appropriate’ by the ACR and is certainly better than no MRI. Non-contrast sequences (like T2 and STIR) are excellent for detecting demyelinating plaques. However, you will lose the ability to assess for active inflammation, which is crucial for diagnosis and management decisions. This represents a trade-off that should be discussed with the patient and the consulting neurologist. In cases of severe allergy, pre-medication protocols may allow for safe contrast administration.

What if the MRI shows a long spinal cord lesion spanning three or more vertebral segments?

This finding, known as longitudinally extensive transverse myelitis (LETM), is a red flag that should raise suspicion for diagnoses other than typical MS. LETM is a classic feature of Neuromyelitis Optica Spectrum Disorder (NMOSD) and can also be seen in MOG Antibody Disease (MOGAD) or sarcoidosis. This imaging finding makes serologic testing for AQP4 and MOG antibodies an urgent next step, as the treatment for these conditions differs significantly from MS.

Can I use CT myelography for this workup?

No, CT myelography is rated ‘Usually not appropriate’ for this clinical scenario. It is an invasive procedure that involves a lumbar puncture to inject contrast into the thecal sac. While it is useful for evaluating structural issues like spinal stenosis or CSF leaks, it is not designed to visualize intrinsic inflammatory or demyelinating lesions within the spinal cord parenchyma. MRI provides superior, non-invasive visualization of these processes.

Reviewed by Pouyan Golshani, MD, Interventional Radiologist — May 30, 2026